高级检索
当前位置: 首页 > 详情页

Assessment of the CKD-EPI Equation to Estimate Glomerular Filtration Rate in Adults from a Chinese CKD Population

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, Wuhan 430030, Hunan, Peoples R China [2]Huazhong Univ Sci & Technol, Tongji Hosp, Div Geriatr, Tongji Med Coll, Wuhan 430030, Hunan, Peoples R China [3]Zhongxiang Renmin Hosp, Dept Internal Med, Zhongxiang, Hubei, Peoples R China [4]Huazhong Univ Sci & Technol, Union Hosp, Div Nephrol, Tongji Med Coll, Wuhan 430030, Hunan, Peoples R China
出处:
ISSN:

关键词: CHRONIC KIDNEY DISEASE CHINESE PATIENTS (TC)-T-99M-DIETHYLENETRIAMINE PENTA-ACETATE GLOMERULAR FILTRATION RATE EQUATION CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION (CKD-EPI) MODIFICATION OF DIET IN RENAL DISEASE (MDRD)

摘要:
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was introduced to estimate glomerular filtration rate (GFR) in chronic kidney disease (CKD) patients based on serum creatinine. The CKD-EPI equation shows better accuracy compared with the current gold standard equation, the Modification of Diet in Renal Disease (MDRD) equation, but it has not been externally validated in Chinese patients. This study compared the CKD-EPI equation with the original MDRD equation and two Chinese MDRD-based equations for estimating GFR in 200 Chinese CKD patients. The Tc-99m-diethylenetriamine penta-acetate (Tc-99m-DTPA) method was used to determine actual GFR. The CKD-EPI equation produced GFR estimates that were more consistent with the Tc-99m-DTPA GFR than did the MDRD equations. The precision and accuracy of the CKD-EPI equation were significantly higher than those of the MDRD equations. In conclusion, the CKD-EPI equation was superior to the existing MDRD equations in terms of estimating GFR and we recommend its clinical use in Chinese CKD patients.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2010]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2009]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2009版] 出版当年五年平均 出版前一年[2008版] 出版后一年[2010版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, Wuhan 430030, Hunan, Peoples R China [3]Zhongxiang Renmin Hosp, Dept Internal Med, Zhongxiang, Hubei, Peoples R China
通讯作者:
通讯机构: [1]Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, Wuhan 430030, Hunan, Peoples R China [*1]Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hunan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:2 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)